In 2015, researcher Jean-Christophe Beaisle-Pipon made a request of the Quebec Access to Information Commission seeking the price paid by the Quebec government for a dose of Bexsero (meningococcal) vaccine (GSK).

It's well documented that the use of specialty medications, however defined, will continue to rise. This is a great news story for patients and the health care practitioners who manage the treatment of some life-changing conditions.

Medical Science Liaisons (MSLs) have been around for about 50 years. Upjohn Pharmaceuticals first created this unique position in 1967, aimed at building relationships and research collaborations with Key Opinion Leaders (KOLs).

Pangaea is currently assisting Biotech and Pharmaceutical clients to benchmark MSL Activity in Canada through their participation in a MSL Benchmarking study.

McKesson Canada presented their acquisition offer during a special assembly with the pharmacists/ shareholders of Uniprix in early May. 2017.

As part of the 2018 budget unveiled last Thursday, Ontario announced it’s new "OHIP+: Children and Youth Pharmacare" plan, a publicly funded drug coverage program for youth up to the age of 24.

The legal dispute between the Health Minister and the AQPP has found a resolution with a new agreement.

To be held Wednesday May 24th at the Canadian Consulate in Boston.

Health Canada has released a white paper outlining its proposed initiative to make specified clinical information from drug submissions and medical device applications publicly available following the completion of its regulatory review process.

Depending on how one approaches the questions posed by this article’s title, the answers are either crystal clear or clear as mud. And here’s why.